[go: up one dir, main page]

PT100077A - Antagonistas da hormona de libertacao da hormona luteinizante e seu processo de preparacao - Google Patents

Antagonistas da hormona de libertacao da hormona luteinizante e seu processo de preparacao

Info

Publication number
PT100077A
PT100077A PT100077A PT10007792A PT100077A PT 100077 A PT100077 A PT 100077A PT 100077 A PT100077 A PT 100077A PT 10007792 A PT10007792 A PT 10007792A PT 100077 A PT100077 A PT 100077A
Authority
PT
Portugal
Prior art keywords
hormone
liberation
antagonists
preparation process
luteinizing
Prior art date
Application number
PT100077A
Other languages
English (en)
Other versions
PT100077B (pt
Inventor
Andrew V Schally
Tamas Janaky
Atilla Juhasz
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of PT100077A publication Critical patent/PT100077A/pt
Publication of PT100077B publication Critical patent/PT100077B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/32—Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT100077A 1991-01-30 1992-01-30 Antagonistas da hormona de libertacao da hormona luteinizante e seu processo de preparacao PT100077B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/647,786 US5171835A (en) 1988-10-21 1991-01-30 LHRH antagonists

Publications (2)

Publication Number Publication Date
PT100077A true PT100077A (pt) 1993-04-30
PT100077B PT100077B (pt) 1999-06-30

Family

ID=24598270

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100077A PT100077B (pt) 1991-01-30 1992-01-30 Antagonistas da hormona de libertacao da hormona luteinizante e seu processo de preparacao

Country Status (13)

Country Link
US (1) US5171835A (pt)
EP (1) EP0522152A1 (pt)
JP (1) JPH05505630A (pt)
CA (1) CA2079461A1 (pt)
FI (1) FI924405A7 (pt)
HU (1) HUT63635A (pt)
IE (1) IE920287A1 (pt)
LV (1) LV5806B4 (pt)
MX (1) MX9200342A (pt)
PT (1) PT100077B (pt)
TW (1) TW304198B (pt)
WO (1) WO1992013883A1 (pt)
ZA (1) ZA92600B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429186B1 (en) 1991-05-10 2002-08-06 Genentech, Inc. Ligand antagonists for treatment of breast cancer
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
ATE206136T1 (de) * 1992-12-18 2001-10-15 Abbott Lab Lhrh antagonisten mit modifizierten aminoacylresten an den positionen 5 und 6
ATE221387T1 (de) * 1993-04-27 2002-08-15 United Biomedical Inc Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US6048863A (en) * 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
WO1996003138A1 (en) * 1994-07-22 1996-02-08 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
AU7333496A (en) * 1995-10-19 1997-05-07 Takeda Chemical Industries Ltd. Quinoline derivatives as gnrh antagonists
CN1063446C (zh) * 1995-10-19 2001-03-21 武田药品工业株式会社 作为促性腺激素释放激素拮抗剂的噻吩并吡啶衍生物
US5828149A (en) * 1996-07-18 1998-10-27 Baker Hughes Incorported Lubricant inducer pump for electrical motor
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
FR2788527A1 (fr) 1999-01-15 2000-07-21 Bio Merieux Pseudopeptide, procede de synthese, reactif et applications
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
WO2001009165A2 (en) * 1999-07-29 2001-02-08 The Johns Hopkins University ACTIVATION OF PEPTIDE PRODRUGS BY hK2
EP1297850B1 (en) * 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Medicinal preparations for treating sex hormone-dependent diseases
US6583153B2 (en) 2000-12-12 2003-06-24 Ortho-Mcneil Pharmaceutical, Inc. 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
EP1479684A4 (en) 2002-01-30 2006-01-04 Takeda Pharmaceutical THIENOPYRIMIDINES, METHODS OF MAKING AND USING SAME
AU2004313245B2 (en) 2003-12-30 2011-04-14 Durect Corporation Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
JP5728380B2 (ja) 2008-06-12 2015-06-03 シンタクシン リミテッドＳｙｎｔａｘｉｎ Ｌｉｍｉｔｅｄ 神経内分泌疾患の抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
RU2674977C2 (ru) 2013-10-30 2018-12-14 Шанхай Хэнжуй Фармасьютикал Ко., Лтд. Производные пиразолопиримидона или пирролотриазона, способ их получения и их фармацевтические применения
EP4004001B1 (en) 2019-07-29 2025-09-03 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
CN118159541A (zh) 2021-11-01 2024-06-07 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
FI832053A7 (fi) * 1982-06-10 1983-12-11 Syntex Inc LHRH-antagonistina käyttökelpoinen LHRH:n nonapeptidi- ja dekapeptidianalogit sekä niiden valmistusmenetevalmistusmenetelmä.
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0364819A3 (en) * 1988-10-21 1991-03-06 The Administrators of The Tulane Educational Fund Lhrh analogs
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
FI924405A0 (fi) 1992-09-30
MX9200342A (es) 1992-08-01
PT100077B (pt) 1999-06-30
JPH05505630A (ja) 1993-08-19
IE920287A1 (en) 1992-07-29
FI924405A7 (fi) 1992-09-30
LV5806B4 (lv) 1997-06-20
LV5806A4 (lv) 1997-02-20
CA2079461A1 (en) 1992-07-31
HU9202778D0 (en) 1992-12-28
TW304198B (pt) 1997-05-01
WO1992013883A1 (en) 1992-08-20
US5171835A (en) 1992-12-15
ZA92600B (en) 1992-10-28
EP0522152A1 (en) 1993-01-13
HUT63635A (en) 1993-09-28

Similar Documents

Publication Publication Date Title
PT100077A (pt) Antagonistas da hormona de libertacao da hormona luteinizante e seu processo de preparacao
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
IL124554A0 (en) Antagonists of gonadotropin releasing hormone
IL124613A0 (en) Antagonists of gonadotropin releasing hormone
BR9302299A (pt) Implante protético e seu processo de realização
IL93085A0 (en) Extended integration semiconductor structure and method of making the same
EP0506980A4 (en) Structure of semiconductor device and manufacturing method thereof
KR900015317A (ko) 단일집적회로의 칩내에 수직형 바이폴라 트랜지스터와 고압 cmos트랜지스터를 형성하는 공정
DE69333336D1 (de) Isolatorstruktur und zugehöriges Herstellungsverfahren
BR9201622A (pt) Processo de formacao de um dispositivo de comutacao limited e dispositivo de comutacao
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
BR9005749A (pt) Tela e processo de preparacao da tela
BR9206140A (pt) Dispositivo de retenção e processo de reter artigos
EP0407133A3 (en) Semiconductor device and method of manufacturing such semiconductor device
EP0451632A3 (en) Semiconductor structure and method of its manufacture
DE69026301D1 (de) Supraleitende Einrichtung und deren Herstellungsverfahren
IT8347699A0 (it) Miscele di fsh e lh da ipofisi porcine in rapporto definito
EP0729659A4 (en) IMPROVED SEMICONDUCTOR ARCHITECTURE AND ITS APPLICATION
BR9002736A (pt) Curral dobravel aperfeicoado e seu processo de montagem
PT86237A (pt) Projectil tubular e seu processo de fabrico
BR9305547A (pt) Zeólito y desaluminizado e seu processo de preparação
PT100000A (pt) Processo de preparacao de extractos de tanacetum parthenium contendo sesquiterpeno-lactona extractos e composicoes farmaceuticas
FI933142A7 (fi) Valettu silikaattipohjainen pesuaine ja sen valmistumenetelmä
KR970008270B1 (en) Manufacturing process of semiconductor device and photoresist composition used therein
EP0429950A3 (en) Junction field effect transistor and method of fabricating

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19921223

FG3A Patent granted, date of granting

Effective date: 19990317

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000930